Veterinary Medicines

TASVAX HUIT

Not authorised
  • Clostridium chauvoei, strain BPLG, Inactivated
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium novyi, type B, toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium chauvoei, strain 3796, Inactivated
  • Clostridium chauvoei, strain P459, Inactivated
Download as PDF

Product identification

Medicine name:
TASVAX HUIT
Active substance:
  • Clostridium chauvoei, strain BPLG, Inactivated
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium novyi, type B, toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium chauvoei, strain 3796, Inactivated
  • Clostridium chauvoei, strain P459, Inactivated
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium chauvoei, strain BPLG, Inactivated
    1.00
    90% protective dose in guinea pig
    /
    1.00
    unit(s)
  • Clostridium perfringens, type A, alpha toxoid
    1.60
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)
  • Clostridium novyi, type B, toxoid
    3.90
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)
  • Clostridium septicum, toxoid
    4.40
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)
  • Clostridium tetani, toxoid
    2.30
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)
  • Clostridium perfringens, type C, beta toxoid
    13.10
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)
  • Clostridium perfringens, type D, epsilon toxoid
    4.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)
  • Clostridium chauvoei, strain 3796, Inactivated
    1.00
    90% protective dose in guinea pig
    /
    1.00
    unit(s)
  • Clostridium chauvoei, strain P459, Inactivated
    1.00
    90% protective dose in guinea pig
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6594261 7/1983
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download